SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending due to heightened investor anticipation surrounding Greenland's rare earth sector and reports of Japan dispatching an official delegation to evaluate extraction opportunities in the region. The community is actively discussing the potential for a technical breakout, the strategic importance of the Tanbreez deposit, and the status of project infrastructure updates.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SPCX is seeing intense retail and institutional focus driven by its massive IPO, index inclusion mandates that force passive funds to buy despite valuation concerns, and bold claims regarding future trillion-dollar revenue potential. The community remains deeply divided, with bulls betting on SpaceX's dominant role in the future space economy, while skeptics view the current valuation as an extreme bubble fueled by hype and lack of fundamental profitability.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending as investors debate the potential market impact of a proposed US-Iran peace deal and its implications for broader energy and geopolitical stability. Social media conversation is highly polarized, with users fiercely debating the deal's legitimacy and the firm's leadership in the context of recent market volatility.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candel Therapeutics is trending as the community highlights the publication of robust Phase 3 trial data in The Lancet Oncology, fueling discussions around its potential as a practice-changing prostate cancer treatment. Investors are closely monitoring upcoming milestones, including the start of a Phase 3 trial for NSCLC and the anticipation of a strategic buyout or partnership, while many actively accumulate shares on pullbacks to position for expected future value.

Rolls-Royce Holdings Plc designs, develops, manufactures, and services integrated power systems for use in the air, on land, and at sea. The company operates its business through following segments: Civil Aerospace, Power Systems, Defense and New Markets. The Civil Aerospace segment offers commercial aero engines and aftermarket services. The Power Systems segment includes engines, power systems and nuclear systems for civil power generation. The Defense segment consists of military aero engines, naval engines, submarines and aftermarket services. The New Markets segment includes development, manufacture and sales of small modular reactors (SMRs) and new electrical power solutions. The company was founded in March 1906 and is headquartered in London, the United Kingdom.

Rolls-Royce Holdings Plc - ADR

Rolls-Royce Holding PLC (ADR)

Rolls-Royce is trending as the community highlights recent contract wins for its SMR division and strong performance in engine fleet efficiency, fueling optimism ahead of upcoming earnings reports. Investors are actively debating the stock's resilience against geopolitical volatility, with many viewing current price fluctuations as a long-term accumulation opportunity supported by robust defense and nuclear energy prospects.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflix is facing intense debate among retail investors, with sentiment split between bearish frustration over its lackluster price action and bullish accumulation driven by its dominant global market position and advertising growth. The stock remains a focal point for the community due to ongoing institutional buying interest that contrasts sharply with the vocal skepticism of retail traders who are questioning the stock's recent performance compared to broader market trends.

Sandisk Corp. engages in the development, manufacture, and provision of storage devices and solutions based on NAND flash technology. Its products include solid state drives, memory cards, and USB flash drives. The company was founded on February 5, 2024 and is headquartered in Milpitas, CA.

Sandisk Corp

Sandisk is experiencing intense trading activity as its rapid, parabolic ascent toward the $2,000 level triggers a fierce standoff between bullish momentum chasers and bears betting on an inevitable correction. Community conversation is dominated by debates over AI-driven memory demand versus fears of an unsustainable bubble, with many traders actively monitoring geopolitical news and potential stock splits as the next major catalysts.

General Motors Co. engages in the designing, manufacturing, and selling of trucks, crossovers, cars, and automobile parts, and in providing software-enabled services and subscriptions. It operates through the following segments: GMNA, GMI, Cruise, and GM Financial. The company was founded by William C. Durant on September 16, 1908 and is headquartered in Detroit, MI.

General Motors Company

General Motors is trending as investors digest a substantial $7.1 billion fourth-quarter charge linked to a strategic pullback from electric vehicle initiatives and a restructuring of their China joint venture. While these write-downs weigh on near-term financials, the market is closely watching how this pivot toward internal combustion stability and cost-discipline shapes the company's long-term profitability and competitive positioning against industry peers.

Intellia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

Intellia Therapeutics is currently a focal point for the investment community following positive Phase 3 results for its in vivo gene-editing therapy, Lonvo-z, which has effectively de-risked its platform and signaled a clear path toward commercialization. Investors are actively debating the significance of the companys recent stock offering and the potential for a short squeeze, while highlighting the transformative HAE market opportunity and sustained institutional interest despite broader sector volatility.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

TG Therapeutics is trending due to positive Phase 1 clinical data for subcutaneous Briumvi, which suggests potential for at-home administration and expansion into myasthenia gravis treatment. Investors are actively discussing the stock's buyout potential and market share growth, while closely monitoring upcoming institutional fireside chats for further catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$GTN doubled my position in the $4.60s this morning after selling 80% last year in the low sixes. ￼ That raised my PPS a little, but no big deal.  My target is roughly 7 dollars mid f1QTR27 after the midterms and before the earnings GLTA

Skyr

Mika Lehtinen

StockTwits for iOS

Gray Television, Inc.

 doubled my position in the $4.60s this morning after selling 80% last year in the low sixes. ￼ That raised my PPS a little, but no big deal.  My target is roughly 7 dollars mid f1QTR27 after the midterms and before the earnings GLTA